These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7969167)

  • 1. Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BP1, and 53BP2.
    Thukral SK; Blain GC; Chang KK; Fields S
    Mol Cell Biol; 1994 Dec; 14(12):8315-21. PubMed ID: 7969167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2.
    Iwabuchi K; Li B; Massa HF; Trask BJ; Date T; Fields S
    J Biol Chem; 1998 Oct; 273(40):26061-8. PubMed ID: 9748285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of Rad51 and other peptide sequences to a promiscuous, highly electrostatic binding site in p53.
    Friedler A; Veprintsev DB; Rutherford T; von Glos KI; Fersht AR
    J Biol Chem; 2005 Mar; 280(9):8051-9. PubMed ID: 15611070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor.
    Derbyshire DJ; Basu BP; Serpell LC; Joo WS; Date T; Iwabuchi K; Doherty AJ
    EMBO J; 2002 Jul; 21(14):3863-72. PubMed ID: 12110597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2.
    Gorina S; Pavletich NP
    Science; 1996 Nov; 274(5289):1001-5. PubMed ID: 8875926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cellular proteins that bind to wild-type but not mutant p53.
    Iwabuchi K; Bartel PL; Li B; Marraccino R; Fields S
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6098-102. PubMed ID: 8016121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure.
    Joo WS; Jeffrey PD; Cantor SB; Finnin MS; Livingston DM; Pavletich NP
    Genes Dev; 2002 Mar; 16(5):583-93. PubMed ID: 11877378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition.
    Datta B; Li B; Choubey D; Nallur G; Lengyel P
    J Biol Chem; 1996 Nov; 271(44):27544-55. PubMed ID: 8910340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53-binding protein 2 (53BP2).
    Tidow H; Veprintsev DB; Freund SM; Fersht AR
    J Biol Chem; 2006 Oct; 281(43):32526-33. PubMed ID: 16887812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.
    Ekblad CM; Friedler A; Veprintsev D; Weinberg RL; Itzhaki LS
    Protein Sci; 2004 Mar; 13(3):617-25. PubMed ID: 14978302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of p53 and p105-RB is not sufficient for oncogenic transformation by a hybrid polyomavirus-simian virus 40 large T antigen.
    Manfredi JJ; Prives C
    J Virol; 1990 Nov; 64(11):5250-9. PubMed ID: 2214017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor suppressor p53 and the oncoprotein simian virus 40 T antigen bind to overlapping domains on the MDM2 protein.
    Brown DR; Deb S; Muñoz RM; Subler MA; Deb SP
    Mol Cell Biol; 1993 Nov; 13(11):6849-57. PubMed ID: 8413278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered phosphorylation of free and bound forms of monkey p53 and simian virus 40 large T antigen during lytic infection.
    Tack LC; Wright JH
    J Virol; 1992 Mar; 66(3):1312-20. PubMed ID: 1310751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-protein interactions occur between p53 phosphoforms and ATM and 53BP1 at sites of exogenous DNA damage.
    Al Rashid ST; Harding SM; Law C; Coackley C; Bristow RG
    Radiat Res; 2011 May; 175(5):588-98. PubMed ID: 21361779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor.
    Lilyestrom W; Klein MG; Zhang R; Joachimiak A; Chen XS
    Genes Dev; 2006 Sep; 20(17):2373-82. PubMed ID: 16951253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human PTIP facilitates ATM-mediated activation of p53 and promotes cellular resistance to ionizing radiation.
    Jowsey PA; Doherty AJ; Rouse J
    J Biol Chem; 2004 Dec; 279(53):55562-9. PubMed ID: 15456759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage.
    Anderson L; Henderson C; Adachi Y
    Mol Cell Biol; 2001 Mar; 21(5):1719-29. PubMed ID: 11238909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of a protein-binding domain of p53.
    Ruppert JM; Stillman B
    Mol Cell Biol; 1993 Jun; 13(6):3811-20. PubMed ID: 8388547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways.
    Rappold I; Iwabuchi K; Date T; Chen J
    J Cell Biol; 2001 Apr; 153(3):613-20. PubMed ID: 11331310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.